Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 57103-68-1
2. Zwj9a2aj2u
3. Nsc-239386
4. Refchem:156011
5. 950-267-0
6. Unii-zwj9a2aj2u
7. Ansamitocin P-0
8. 3-o-de(2-(acetylmethylamino)-1-oxopropyl)maytansine
9. Mfcd28144515
10. (14s,16s,32s,33s,2r,4s,10e,12e,14r)-86-chloro-14,4-dihydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-diene-12,6-dione
11. Maytansine, 3-o-de(2-(acetylmethylamino)-1-oxopropyl)-
12. (1s,2r,3s,5s,6s,16e,18e,20r,21s)-11-chloro-6,21-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaene-8,23-dione
13. C28h37cln2o8
14. Ansamitocin P 0
15. Ansamitocin P 0; Antibiotic C 15003p0; Nsc 239386; 3-o-de[2-(acetylmethylamino)-1-oxopropyl]maytansine
16. Maytansinol; Ansamitocin P-0
17. Maytansinol(ansamitocin P-0)?
18. Schembl13558643
19. Qwpxbehqfhactk-rzkxnlmusa-n
20. Ex-a2656
21. Cs-5322
22. Fm44850
23. Hy-19474
24. 3-o-de[2-[methyl(acetyl)amino]-1-oxopropyl]maytansine
Molecular Weight | 565.1 g/mol |
---|---|
Molecular Formula | C28H37ClN2O8 |
XLogP3 | 1.5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 2 |
Exact Mass | Da |
Monoisotopic Mass | Da |
Topological Polar Surface Area | 130 |
Heavy Atom Count | 39 |
Formal Charge | 0 |
Complexity | 993 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE